{"name":"Glycomine, Inc.","slug":"glycomine-inc","ticker":"","exchange":"","domain":"glycomine.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"GLM101","genericName":"GLM101","slug":"glm101","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"GLM101","genericName":"GLM101","slug":"glm101","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxQdmcxZ09QTFI2TDg5dklod0IwTDlOYW1zcERhY2ZIMDhuNm1XQ1hYZnJkWFB4eWlENzlsVnZBclQ2dnhKNHE0SGVoOGEwTTdoX2tqYkRHVGVvazJuRmNqR245RHJRbnFrbkdPNDhmcmpxNnRObHRGajlRTGRtdjRvZ0xzdjhGOFQweWJ3RWhTUU00SlE0Qi1LU3BnR0I3R01Lb3BrTXdIVThjRkZBUURaX3RBVm5vcUVxaWs4?oc=5","date":"2025-10-14","type":"pipeline","source":"Inside Precision Medicine","summary":"Five Key Startups Shining the Light on Rare Diseases - Inside Precision Medicine","headline":"Five Key Startups Shining the Light on Rare Diseases","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAJBVV95cUxPRW9vemFYcVVJV2JrcDNKRVY3emFrUjVjUlZ2TDVyUE9XWFJjcDZwRTBIYUFBX0hfaUtTRkltall0Nkg4Wk8zNTJRYkU1R1FhV3BoYTFveTNuUnVlZHlFZTB0RVJUanBpeWlCbGpiZW1EU1pyenBiNUFwSjdVWjNrbUY2Ql9Od2ZiMU9NY01tUVZ1YjhRZG14LV9UbGpaRXBEZk5RXzVDMkhCbGRybWJybTZaWW5USVV5b3M1TW42UTEyVmlVNVZweUNMa256SnlubDF6RzVRMlNJWFA0c0dFZlhHX3dPaTQ1TTc4ZmhsRmRHUVlEbzRrUTVaUDUwUHFQMDJ3d3ZTdjZoMmlN?oc=5","date":"2025-09-03","type":"trial","source":"Business Wire","summary":"Glycomine Initiates Dosing in a Global, Randomized, Placebo-Controlled Phase 2b Study of GLM101 for the Treatment of PMM2-CDG - Business Wire","headline":"Glycomine Initiates Dosing in a Global, Randomized, Placebo-Controlled Phase 2b Study of GLM101 for the Treatment of PMM","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQcER4bUMzRlBYWGVlREs1WWpTV3N4d2F4U19TUi1qcUhiQS1SR2tNRFd0RTJhakxER2JYb3d4eXlsNjNsaHdQeXREWWRzS29wazV0TEREblJqTUh6TXppa0xsQTFkZVdqOVNLMXlJOGk1ck9JZUtTZU15SlV6bTBZRlI0Z3B6VVpGb05jdFlmc2lPQQ?oc=5","date":"2025-04-16","type":"pipeline","source":"BioPharma Dive","summary":"Startup Glycomine raises $115M to push rare disease drug deeper into testing - BioPharma Dive","headline":"Startup Glycomine raises $115M to push rare disease drug deeper into testing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBaY1VZZ3FpLW4waXR2aG5SU0tEQXpQdXRPcVpwcy1ZRFFmbElBZzVUMUZPemVVXy1NZ0VXMlljS1dmSXd4ZGo4MzV3enpXcmQxVGdv?oc=5","date":"2025-04-16","type":"trial","source":"FirstWord Pharma","summary":"Glycomine gears up for potentially pivotal rare disease study with fresh $115M - FirstWord Pharma","headline":"Glycomine gears up for potentially pivotal rare disease study with fresh $115M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAJBVV95cUxQRno4dk9vS3ZqWVB1N2lTdi1vZWQ2NE5yOERPd0VPOG9qazlfOWxnNFhHNGpqSTg2ZzBUOFlXZ0pNNVlTbzFEa2RpTE9hN0s1UDZYV0tPWmZNQWtKZ1NQX0Y2d2pkM0d5cHBfUHF3MEoxVGQtRElEOU9VcTBJeVdzTzkzSUtkV1REZEdtZzhrUHpPOERwRVVxTVRNZE1xN2VDRnFBX0o4Q3pSOUpPWkE0OWltSU1Gak5HUU1FaEdGdEI1dDJ1REt3aHgwamFDVXItSGpCdzdST1B1b0ZuUEJCczNDWFBPN3V0bU5yenFvendPSmJOMWRWMV9SRmR1UHNDSFBtaVgyNnJPVGc5cXFEV2o0aS1WTFZTYkJMTA?oc=5","date":"2025-04-16","type":"trial","source":"Business Wire","summary":"Glycomine Announces $115 Million Series C Financing to Advance Lead Drug Candidate, GLM101, into a Phase 2b Clinical Trial for PMM2-CDG - Business Wire","headline":"Glycomine Announces $115 Million Series C Financing to Advance Lead Drug Candidate, GLM101, into a Phase 2b Clinical Tri","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxNcURUVURMYW54MzFZRnY3MlFOcEpWNHRzcFF6MkNJdzdmaThRaWxiMGlrN0Q2TENDd2hXaWh1RmpEMm11V2d0RVBybFRSWUdGbVVWV1BOQjNqQV9UekJDR2gwVjRCMGIyU3ZtQkRyX25odE4tM3ZiT1dqT3RLYU9YNDl2UXVLZDJXbHQyZk5HV0gtSXJfd3gzeWU2dkRBS0JEWWRyT0FDSVlCTXlmQ3FCV3U5RDlvN2FYcHhOaTNiQ1NfT3ozUkM3UlJTbllSUkRfdUpTOVM4VUk?oc=5","date":"2025-04-16","type":"trial","source":"Inside Precision Medicine","summary":"Glycomine Raises $115M for Phase IIb of Genetic Glycosylation Disorder Drug - Inside Precision Medicine","headline":"Glycomine Raises $115M for Phase IIb of Genetic Glycosylation Disorder Drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNUDNTWElYdlVFbUNIdWd1eDYySGZQeU5femlNV2xTYUYxZWp0bnlYeUxKT0VuVzdFWV85Z1plOHI5UzJvVVN0cHVtY2p4MjBNc0pEc2xZNjZGbEMzYWpsOGVvY2VjeGduaDd5RzExS3FWY3hkUlFaNFZLQ1g3M2w4SGl3eFl3S2hWNWdCemdIYjVkZGVCODRVbUdKdU5IQ21JYUpNOWhHNE9MbnJ5?oc=5","date":"2024-10-10","type":"pipeline","source":"BioSpace","summary":"Glycomine Appoints Joshua Grass as Chairperson of Board of Directors - BioSpace","headline":"Glycomine Appoints Joshua Grass as Chairperson of Board of Directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxOYy1pMy1malBvUldyUldwb19qM183Sk5fWHBtb1E2czVIOTRmbDNLN1VpNWJ4aTZYWHJ5ZVh2UHVQdVg4c2NuemZIVW80T2VxdWdFc0FWcXpUaHhpeGVsRUhESEdtUXI2RFYtaGFYbDFYTzVDSnc5dlRLcWRSbDlRVWhCUHFWMG12VXlGeU5yTG4wS21vbjc3N0p5dTg1bENiX01qWDdGdGF0eU1PdXV5cDMzSVNxLW5sb0xJSzJPMUxlRDdvU1hyTktPSTBkZ0RPeVpDS3JpQVFaVkE?oc=5","date":"2024-09-18","type":"regulatory","source":"Business Wire","summary":"Glycomine Receives FDA Fast Track Designation for GLM101 for the Treatment of PMM2-CDG - Business Wire","headline":"Glycomine Receives FDA Fast Track Designation for GLM101 for the Treatment of PMM2-CDG","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAJBVV95cUxNdXN4amMxcm85NGduZVpOd2FyaGl2TTA4Zjl1RVRybzAyZk9aQkxUMFJ4bWwtald2c1FPLWdNVUQxY0hMckRGVkVUQ1ZNemFEdXZBT1Iza3lNbDdRalA5ZWJJSHZyTldjeVU2NTR6WUVLYUlZQ0J0YUhNQ0d1Njhsby1kaFQzM0dTZEsxLUhhSUQ0WUpOX1VhLVVSc054WXNiYTZpSEhvbXozamdzNDk5NmxXM01MRUJXelBENnVlQTFPOFh2STFiV2VJcU9FdzJyY1F0djdzYTNId3cybHE4U1J0bzNCcW91cE4xYzVRLURTSDE4dHBxazl1SVZLUDc4WWowZg?oc=5","date":"2019-08-07","type":"pipeline","source":"PR Newswire","summary":"Glycomine, Inc. Announces $33 Million Series B Financing to Advance its Therapy for a Congenital Disease of Glycosylation - PR Newswire","headline":"Glycomine, Inc. Announces $33 Million Series B Financing to Advance its Therapy for a Congenital Disease of Glycosylatio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAJBVV95cUxPTFd5aGRDeFA2NDR6RFZaZGg3UW5GcVppa1NUcWU1VUhGVnlDZk8ydm02dTVLWnhVaVN2Y0xOTDRZcDUyQThNXy1ia3RTSEp1aDhCRVhYWF80aGJCX2dhSGZLTmtvS0FVaVdGY1VMNjN3WXV1T3FQeWtzczI3MWxHdDU4NmFaY0N2WlhRelVOcl9sSzhDSWN6WDkwZHB4MFg2WXdRWTIzVHBEVXRub1hHd20wMldEdEJDSVE3LXlKUUNoVmQ5ejBBSThzWEdwS29TS0p0X0gxejZWOWlZc3h6RmZsazdUTEo4d3k1RkxKemJCMktyX0w3TVpZRVNxQmw1Yl9Vc05raHU5R1lZ?oc=5","date":"2016-11-16","type":"pipeline","source":"PR Newswire","summary":"Glycomine, Inc. Announces $12 Million Series A Financing to Advance a New Generation of Replacement Therapies for Rare Diseases - PR Newswire","headline":"Glycomine, Inc. Announces $12 Million Series A Financing to Advance a New Generation of Replacement Therapies for Rare D","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}